Pramiconazole - Misplaced Pages

This is the current revision of this page, as edited by DMacks (talk | contribs) at 04:23, 25 March 2024 (auto mw). The present address (URL) is a permanent link to this version.

Revision as of 04:23, 25 March 2024 by DMacks (talk | contribs) (auto mw)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Pramiconazole" – news · newspapers · books · scholar · JSTOR (January 2021) (Learn how and when to remove this message)

Pharmaceutical compound

Pramiconazole
Clinical data

Routes of administration	By mouth
ATC code	none
Identifiers
IUPAC name 1-{4-methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one
CAS Number	219923-85-0
PubChem CID	3013050 11411233
ChemSpider	2281806
UNII	4SYH0R661F
ChEMBL	ChEMBL175797
Chemical and physical data
Formula	C₃₅H₃₉F₂N₇O₄
Molar mass	659.739 g·mol
3D model (JSmol)	Interactive image
SMILES CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC5OC(O5)(Cn6cncn6)c7ccc(cc7F)F
InChI InChI=1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1 Key:AEKNYBWUEYNWMJ-QWOOXDRHSA-N
(what is this?) (verify)

Pramiconazole is a triazole antifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.

References

"Pramiconazole - AdisInsight".
Geria AN, Scheinfeld NS (September 2008). "Pramiconazole, a triazole compound for the treatment of fungal infections". IDrugs: The Investigational Drugs Journal. 11 (9): 661–70. PMID 18763217.

Antifungals (D01 and J02)

Wall/
membrane

Ergosterol
inhibitors

Azoles (lanosterol 14α-
demethylase inhibitors)

Imidazoles

Systemic: ketoconazole

Triazoles

Unknown: albaconazole
ravuconazole

Thiazoles

Topical: abafungin

Polyene antimycotics
(ergosterol binding)

Topical: hamycin
natamycin
nystatin
Systemic: amphotericin B, hamycin

Squalene monooxygenase
inhibitors

Allylamines	Topical: naftifine terbinafine Systemic: terbinafine
Benzylamines	Topical: butenafine

Others

Topical: amorolfine

β-glucan synthase
inhibitors

Intracellular

Pyrimidine analogues/ thymidylate synthase inhibitors	Systemic: flucytosine
Mitotic inhibitors	Systemic: griseofulvin
Aminoacyl tRNA synthetase inhibitors	Topical: tavaborole

Others

WHO-EM
Withdrawn from market
Clinical trials:
- Phase III
- Never to phase III

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Categories: